Tissuetech Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

TissueTech is an innovative technology company that uses products derived from human amniotic and umbilical cord tissues. Its medical technology platform markets innovative amniotic and umbilical cord-based products, thereby enabling physicians to avail of enhanced regenerative healing technology in eye care, wound care, and orthopedics. Tissuetech was founded in 2001 and is headquartered in Miami, Florida.

Company Highlights
Year Founded

2001

icon-altEmployees

351

Location (HQ)

USA

Since Last Funding

5 years 4 months

Monthly Website Visitors

10.2K

icon-altTotal Investment Amt

$100M

Last Funding Round

Series C

icon-altMoM Headcount Growth

-0.57%

icon-altYoY Headcount Growth

53.92%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Biotechnology

Medical

Medical Device

Therapeutics

Pharmaceutical

Biotechnology Research